LAUSR

medicine in ARDS. These challenges are currently being tackled by others (https://clinicaltrials.gov/ct2/show/NCT04009330), and it is possible that we will have rapid diagnostics in the not-so-distant future. The best lesson, one that we can act on starting today, is that the bedside to bench to bedside approach is a powerful method for understanding clinically relevant biology. This illustrates that the path toward clinical application of personalized interventions in ARDS requires synchronized research by multiple groups with complementary expertise. If these steps are taken in the coming years, the field may look back at this study as a pioneering step toward a treatable trait approach for ARDS (10).